Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 813 to 862 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
407\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6634.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6983.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05264\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein interacting protein (wasp interacting protein) (prpl-2 protein). [source:swissprot;acc:o43516]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6603.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7664.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16071\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
408\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
l-lactate dehydrogenase c chain (ec 1.1.1.27) (ldh-c) (ldh testis subunit) (ldh-x). [source:swissprot;acc:p07864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
409\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 2 (p56(dok-2)) (downstream of tyrosine kinase 2). [source:swissprot;acc:o60496]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
l-lactate dehydrogenase a chain (ec 1.1.1.27) (ldh-a) (ldh muscle subunit) (ldh-m). [source:swissprot;acc:p00338]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
410\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 1 (p62(dok)) (downstream of tyrosine kinase 1) (pp62). [source:swissprot;acc:q99704]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
max interacting protein 1 (mxi1 protein). [source:swissprot;acc:p50539]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.61\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05263\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
411\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
l-lactate dehydrogenase b chain (ec 1.1.1.27) (ldh-b) (ldh heart subunit) (ldh-h). [source:swissprot;acc:p07195]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6973.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.39\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
412\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
clip-associating protein 1; drosophila 'multiple asters' (mast)-like homolog 1. [source:refseq;acc:nm\_015282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6973.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7340.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05263\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mki67 (fha domain) interacting nucleolar phosphoprotein; nucleolar phosphoprotein nopp34; nucleolar protein interacting with the fha domain of pki-67. [source:refseq;acc:nm\_032390]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3594.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4169.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16015\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
413\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
max-interacting transcriptional repressor mad4 (max-associated protein 4) (max dimerization protein 4). [source:swissprot;acc:q14582]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6974.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7341.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05259\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vav proto-oncogene. [source:swissprot;acc:p15498]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6644.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7707.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15994\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
414\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
autophagy protein 5-like (apg5-like) (apoptosis-specific protein). [source:swissprot;acc:q9h1y0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6744.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5815.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15974\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
max dimerization protein 3; likely ortholog of mouse max dimerization protein 3. [source:refseq;acc:nm\_031300]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6975.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7342.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05258\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
415\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hn1 like. [source:refseq;acc:nm\_144570]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8657.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9111.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05254\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vav-3 protein. [source:swissprot;acc:q9ukw4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6647.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7706.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15927\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
416\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
n-terminal acetyltransferase complex ard1 subunit homolog (ec 2.3.1.-). [source:swissprot;acc:p41227]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4509.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5223.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15842\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transgelin (smooth muscle protein 22-alpha) (sm22-alpha) (ws3-10) (22 kda actin-binding protein). [source:swissprot;acc:q01995]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6972.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7338.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0525\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
417\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amyloid beta precursor protein-binding protein 1; amyloid protein-binding protein 1. [source:refseq;acc:nm\_003905]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7902.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8316.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05243\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-3 (bcl-2 binding athanogene- 3) (bag-3) (bcl-2-binding protein bis) (docking protein cair-1). [source:swissprot;acc:o95817]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4522.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5233.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15708\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
418\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5493.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6350.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15603\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
iroquois-class homeodomain protein irx-4 (iroquois homeobox protein 4). [source:swissprot;acc:p78413]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8958.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9427.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05239\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
419\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
argininosuccinate lyase (ec 4.3.2.1) (arginosuccinase) (asal). [source:swissprot;acc:p04424]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8768.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9227.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05237\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5493.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6350.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15603\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
420\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hypoxanthine-guanine phosphoribosyltransferase (ec 2.4.2.8) (hgprt) (hgprtase). [source:swissprot;acc:p00492]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10235.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11830.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15589\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
latrophilin 3; latrophilin homolog 3 (cow); lectomedin 3. [source:refseq;acc:nm\_015236]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8768.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
9227.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05237\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
421\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
latrophilin 2; lectomedin-1; latrophilin homolog 2 (cow). [source:refseq;acc:nm\_012302]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vav-2 protein. [source:swissprot;acc:p52735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6660.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7697.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15582\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
422\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
latrophilin 1; lectomedin-2; latrophilin homolog 1 (cow). [source:refseq;acc:nm\_014921]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8768.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9227.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05237\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5206.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6010.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15425\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
423\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 3 (tap-like protein 3) (tapl-3). [source:swissprot;acc:q9h4d5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5207.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6010.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15423\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein tyrosine phosphatase, non-receptor type 14 (ec 3.1.3.48) (protein-tyrosine phosphatase pez). [source:swissprot;acc:q15678]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8902.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9368.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0523\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
424\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 1 (tip associating protein) (tip-associated protein) (mrna export factor tap). [source:swissprot;acc:q9ubu9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5207.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6010.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15413\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein tyrosine phosphatase, non-receptor type 21 (ec 3.1.3.48) (protein-tyrosine phosphatase d1). [source:swissprot;acc:q16825]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8902.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9368.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0523\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
425\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related protein rab-7. [source:swissprot;acc:p51149]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8055.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8476.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05226\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
saccharomyces cerevisiae nip7p homolog. [source:refseq;acc:nm\_016101]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3729.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4301.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15354\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
426\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pef protein with a long n-terminal hydrophobic domain (peflin). [source:refseq;acc:nm\_012392]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5942.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6853.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15325\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proton/amino acid transporter 4. [source:refseq;acc:nm\_152313]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8913.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9379.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05223\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
427\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8174.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8601.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05221\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trna (5-methylaminomethyl-2-thiouridylate)-methyltransferase (ec 2.1.1.61). [source:swissprot;acc:o75648]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11736.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13531.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15297\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
428\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal protein np25. [source:swissprot;acc:q9ui15]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6962.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7326.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0522\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar gtp-binding protein 1 (chronic renal failure gene protein) (gtp-binding protein ngb). [source:swissprot;acc:q9bze4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3721.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4288.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15237\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
429\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-box only protein 9. [source:swissprot;acc:q9uk97]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9028.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9499.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05213\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vinexin (sh3-containing adaptor molecule-1) (scam-1). [source:swissprot;acc:o60504]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6272.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7226.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15195\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
430\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sortilin precursor (glycoprotein 95) (gp95) (neurotensin receptor 3) (nt3) (100 kda nt receptor). [source:swissprot;acc:q99523]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8342.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8777.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05205\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor dp-2 (e2f dimerization partner 2). [source:swissprot;acc:q14188]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3804.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4379.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15123\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
431\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3849.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4431.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15102\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
high-affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9a (ec 3.1.4.17). [source:swissprot;acc:o76083]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8906.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9368.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05188\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/